Oasmia Pharmaceutical AB (NASDAQ:OASM) reports that it has terminated its “engagement and cooperation” with former executive chairman Julian Aleksov without further pay.
The company took action following a tax audit that revealed missing funds connected to suspicious transactions between Oasmia and companies controlled by Mr. Aleksov and his former father in-law.
The board has reported the matter to the Swedish Economic Crime Authority.
Shares are down 3% after hours.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.